STOCK TITAN

News for HYDI Stock

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Contract Extensions, and the Launch of New Innovations Hydromer, Inc. Unveils Rebranding Initiatives Reflecting Its Transformation and Focus on Growth and Innovation Hydromer Inc. Announces Formation of its Scientific Advisory Board with the Appointment of its First Member Eric Becktel Hydromer, Inc. Releases Letter to Shareholders from Chairman Braeden Lichti Hydromer Inc. Marks a Formidable Presence: Set to Exhibit at BIOMEDevice Conferences in Boston and Santa Clara Hydromer, Inc. Announces Resignation of Board Members and Appointment of New Directors Hydromer Inc. Shares Message from CEO Michael E. Torti Hydromer Inc Appoints New CEO Hydromer, Inc. Announces Removal of CEO Hydromer Inc. Announces the Addition of Michael Torti as Vice President of Sales, Marketing and Business Development Hydromer Inc., Announces the Addition of Cam Cruickshank, Ph.D. to the Company’s Board of Directors, Replacing the Retiring Mr. Dieter Heinemann Hydromer Announces the Addition of Cortney Wells as the Company's New Director of Finance Hydromer, Inc. Surpasses the 40-Year Mark as a World-Wide Supplier of Specialty Coatings for Medical and Industrial Applications and Announces That Its New Facility in North Carolina is Fully Operational With Extensive New Capabilities Hydromer Inc. is Pleased to Announce the Addition of a New Global Business Development Manager to Propel Growth Hydromer Selected as Key Coatings Provider for Avinger’s Image-Guided PAD Therapeutic Devices
Back to Sitemap